Literature DB >> 24910296

Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin.

Walter Liszewski1, Joy D Wisniewski, Hana Safah, Erin E Boh.   

Abstract

Necrobiotic xanthogranuloma (NXG) is a disease of fibrotic or telangiectatic granulomatous papules and nodules that can ultimately progress into ulcerated plaques. Although the exact cause of NXG is unknown, it most often occurs in patients with paraproteinemia secondary to a hematologic disease. Consequently, therapy for NXG is targeted at treating the underlying hematologic disease, and subsequent paraproteinemia, with alkylating agents, antimetabolites, radiation, and/or immunosuppressive agents. Cases refractory to these therapies often have poor outcomes. We report the successful treatment of two patients with refractory NXG with two different modalities: extracorporeal photopheresis (ECP) and intravenous immunoglobulin (IVIG). The first case shows a patient without paraproteinemia who had success with ECP and IVIG, and the second is a patient with paraproteinemia treated effectively with IVIG. The beneficial response of our patients to IVIG, as well as ECP, shows that they may be an effective treatment option for refractory NXG.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  extracorporeal photopheresis; intravenous immunoglobulin; necrobiotic xanthogranuloma

Mesh:

Substances:

Year:  2014        PMID: 24910296     DOI: 10.1111/dth.12135

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  4 in total

1.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma.

Authors:  Marlies Wruhs; Robert Feldmann; Isabelle Sawetz; Friedrich Breier; Andreas Steiner
Journal:  Case Rep Dermatol       Date:  2016-12-01

3.  Periorbital Necrobiotic Xanthogranuloma Successfully Treated with Intravenous Immunoglobulin.

Authors:  Rose M Olson; Andrew R Harrison; Amanda Maltry; Ali Mokhtarzadeh
Journal:  Case Rep Ophthalmol       Date:  2018-01-17

Review 4.  Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Authors:  Lisa Steinhelfer; Thomas Kühnel; Herbert Jägle; Stephanie Mayer; Sigrid Karrer; Frank Haubner; Stephan Schreml
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.